Clinical Trial: Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

---

Official Title: Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer

Brief Summary:

The purposes of this study are:

• To determine the overall response rate of patients treated with at least 2 cycles of this regimen.
• To determine the feasibility and toxicity of the combination of topotecan and docetaxel.